Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) and OneMedNet (NASDAQ:ONMD – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations and valuation.
Volatility & Risk
Firefly Neuroscience has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Comparatively, OneMedNet has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500.
Valuation and Earnings
This table compares Firefly Neuroscience and OneMedNet”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Firefly Neuroscience | $1.14 million | 14.73 | -$19.88 million | ($0.59) | -1.81 |
| OneMedNet | $1.36 million | 28.45 | -$2.80 million | ($0.16) | -4.08 |
OneMedNet has higher revenue and earnings than Firefly Neuroscience. OneMedNet is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent recommendations and price targets for Firefly Neuroscience and OneMedNet, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Firefly Neuroscience | 1 | 0 | 0 | 0 | 1.00 |
| OneMedNet | 1 | 0 | 0 | 0 | 1.00 |
Profitability
This table compares Firefly Neuroscience and OneMedNet’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Firefly Neuroscience | -506.23% | -90.17% | -72.05% |
| OneMedNet | -584.20% | N/A | -521.20% |
Insider and Institutional Ownership
5.0% of Firefly Neuroscience shares are held by institutional investors. Comparatively, 0.9% of OneMedNet shares are held by institutional investors. 6.9% of Firefly Neuroscience shares are held by insiders. Comparatively, 50.2% of OneMedNet shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
OneMedNet beats Firefly Neuroscience on 7 of the 11 factors compared between the two stocks.
About Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Receive News & Ratings for Firefly Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Firefly Neuroscience and related companies with MarketBeat.com's FREE daily email newsletter.
